Release Date: 02/03/18 17:41 Summary: TOV:Strategic Minerals Corporation NL Review Panel Decision Price Sensitive: No Download Document 127.22KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%